Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Nervenarzt ; 94(11): 1010-1018, 2023 Nov.
Article in German | MEDLINE | ID: mdl-37815590

ABSTRACT

The impacts of nature and climate change on mental health are substantial but the underlying mechanisms are still poorly understood. The immune system in particular could play an important role. Therefore, the German Center for Mental Health (DZPG) in Munich will use state of the art model systems to elucidate the role of the immune system in the pathogenesis of mental disorders under altered environmental conditions and to develop preventive treatment strategies.


Subject(s)
Mental Disorders , Humans , Mental Disorders/etiology , Mental Health , Climate Change
2.
J Cell Biol ; 222(3)2023 03 06.
Article in English | MEDLINE | ID: mdl-36637807

ABSTRACT

To enable rapid propagation of action potentials, axons are ensheathed by myelin, a multilayered insulating membrane formed by oligodendrocytes. Most of the myelin is generated early in development, resulting in the generation of long-lasting stable membrane structures. Here, we explored structural and dynamic changes in central nervous system myelin during development. To achieve this, we performed an ultrastructural analysis of mouse optic nerves by serial block face scanning electron microscopy (SBF-SEM) and confocal time-lapse imaging in the zebrafish spinal cord. We found that myelin undergoes extensive ultrastructural changes during early postnatal development. Myelin degeneration profiles were engulfed and phagocytosed by microglia using exposed phosphatidylserine as one "eat me" signal. In contrast, retractions of entire myelin sheaths occurred independently of microglia and involved uptake of myelin by the oligodendrocyte itself. Our findings show that the generation of myelin early in development is an inaccurate process associated with aberrant ultrastructural features that require substantial refinement.


Subject(s)
Microglia , Myelin Sheath , Optic Nerve , Zebrafish , Animals , Mice , Axons/ultrastructure , Microglia/ultrastructure , Myelin Sheath/ultrastructure , Oligodendroglia/ultrastructure , Optic Nerve/ultrastructure , Microscopy, Electron, Scanning , Phagocytosis , Time-Lapse Imaging
3.
Annu Rev Cell Dev Biol ; 38: 467-489, 2022 10 06.
Article in English | MEDLINE | ID: mdl-35850150

ABSTRACT

Successful immune responses depend on the spatiotemporal coordination of immune cell migration, interactions, and effector functions in lymphoid and parenchymal tissues. Real-time intravital microscopy has revolutionized our understanding of the dynamic behavior of many immune cell types in the living tissues of several species. Observing immune cells in their native environment has revealed many unanticipated facets of their biology, which were not expected from experiments outside a living organism. Here we highlight both classic and more recent examples of surprising discoveries that critically relied on the use of live in vivo imaging. In particular, we focus on five major cell types of the innate immune response (macrophages, microglia, neutrophils, dendritic cells, and mast cells), and how studying their dynamics in mouse tissues has helped us advance our current knowledge of immune cell-mediated tissue homeostasis, host defense, and inflammation.


Subject(s)
Immunity, Innate , Intravital Microscopy , Animals , Inflammation , Intravital Microscopy/methods , Macrophages , Mice
4.
Neuron ; 109(7): 1100-1117.e10, 2021 04 07.
Article in English | MEDLINE | ID: mdl-33606969

ABSTRACT

Aging results in gray and white matter degeneration, but the specific microglial responses are unknown. Using single-cell RNA sequencing from white and gray matter separately, we identified white matter-associated microglia (WAMs), which share parts of the disease-associated microglia (DAM) gene signature and are characterized by activation of genes implicated in phagocytic activity and lipid metabolism. WAMs depend on triggering receptor expressed on myeloid cells 2 (TREM2) signaling and are aging dependent. In the aged brain, WAMs form independent of apolipoprotein E (APOE), in contrast to mouse models of Alzheimer's disease, in which microglia with the WAM gene signature are generated prematurely and in an APOE-dependent pathway similar to DAMs. Within the white matter, microglia frequently cluster in nodules, where they are engaged in clearing degenerated myelin. Thus, WAMs may represent a potentially protective response required to clear degenerated myelin accumulating during white matter aging and disease.


Subject(s)
Microglia/physiology , White Matter/cytology , White Matter/growth & development , Aging/physiology , Alzheimer Disease/genetics , Animals , Apolipoproteins E/genetics , Demyelinating Diseases/pathology , Gene Expression Regulation , Gray Matter/cytology , Gray Matter/growth & development , Immunohistochemistry , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Microglia/ultrastructure , Myelin Sheath/metabolism , Receptors, Immunologic/biosynthesis , Receptors, Immunologic/genetics , Sequence Analysis, RNA , Signal Transduction/physiology , Single-Cell Analysis
5.
Nat Neurosci ; 19(8): 995-8, 2016 08.
Article in English | MEDLINE | ID: mdl-27294511

ABSTRACT

Myelin is synthesized as a multilamellar membrane, but the mechanisms of membrane turnover are unknown. We found that myelin pieces were gradually released from aging myelin sheaths and were subsequently cleared by microglia. Myelin fragmentation increased with age and led to the formation of insoluble, lipofuscin-like lysosomal inclusions in microglia. Thus, age-related myelin fragmentation is substantial, leading to lysosomal storage and contributing to microglial senescence and immune dysfunction in aging.


Subject(s)
Aging/metabolism , Brain/metabolism , Microglia/metabolism , Myelin Sheath/metabolism , Animals , Demyelinating Diseases/chemically induced , Demyelinating Diseases/metabolism , Lipofuscin/metabolism , Mice, Inbred C57BL , Mice, Transgenic
6.
Stem Cells ; 34(8): 2115-29, 2016 08.
Article in English | MEDLINE | ID: mdl-27068685

ABSTRACT

Adult neural stem cells with the ability to generate neurons and glia cells are active throughout life in both the dentate gyrus (DG) and the subventricular zone (SVZ). Differentiation of adult neural stem cells is induced by cell fate determinants like the transcription factor Prox1. Evidence has been provided for a function of Prox1 as an inducer of neuronal differentiation within the DG. We now show that within the SVZ Prox1 induces differentiation into oligodendrocytes. Moreover, we find that loss of Prox1 expression in vivo reduces cell migration into the corpus callosum, where the few Prox1 deficient SVZ-derived remaining cells fail to differentiate into oligodendrocytes. Thus, our work uncovers a novel function of Prox1 as a fate determinant for oligodendrocytes in the adult mammalian brain. These data indicate that the neurogenic and oligodendrogliogenic lineages in the two adult neurogenic niches exhibit a distinct requirement for Prox1, being important for neurogenesis in the DG but being indispensable for oligodendrogliogenesis in the SVZ. Stem Cells 2016;34:2115-2129.


Subject(s)
Adult Stem Cells/cytology , Adult Stem Cells/metabolism , Homeodomain Proteins/metabolism , Lateral Ventricles/cytology , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Oligodendroglia/cytology , Tumor Suppressor Proteins/metabolism , Animals , Body Patterning/genetics , Cell Differentiation/genetics , Cell Lineage/genetics , Cell Movement/genetics , Cells, Cultured , Enhancer Elements, Genetic/genetics , Gene Expression Regulation , Gene Knockdown Techniques , Mice , Neurogenesis/genetics , Olfactory Bulb/cytology , Olfactory Bulb/metabolism , Oligodendrocyte Transcription Factor 2/genetics , Oligodendrocyte Transcription Factor 2/metabolism , Oligodendroglia/metabolism , Promoter Regions, Genetic/genetics , Protein Binding , Receptors, Notch/genetics , Receptors, Notch/metabolism
7.
PLoS Negl Trop Dis ; 5(9): e1295, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21909442

ABSTRACT

BACKGROUND: As a potent CD8(+) T cell activator, peptide vaccine has found its way in vaccine development against intracellular infections and cancer, but not against leishmaniasis. The first step toward a peptide vaccine is epitope mapping of different proteins according to the most frequent HLA types in a population. METHODS AND FINDINGS: Six Leishmania (L.) major-related candidate antigens (CPB,CPC,LmsTI-1,TSA,LeIF and LPG-3) were screened for potential CD8(+) T cell activating 9-mer epitopes presented by HLA-A*0201 (the most frequent HLA-A allele). Online software including SYFPEITHI, BIMAS, EpiJen, Rankpep, nHLApred, NetCTL and Multipred were used. Peptides were selected only if predicted by almost all programs, according to their predictive scores. Pan-A2 presentation of selected peptides was confirmed by NetMHCPan1.1. Selected peptides were pooled in four peptide groups and the immunogenicity was evaluated by in vitro stimulation and intracellular cytokine assay of PBMCs from HLA-A2(+) individuals recovered from L. major. HLA-A2(-) individuals recovered from L. major and HLA-A2(+) healthy donors were included as control groups. Individual response of HLA-A2(+) recovered volunteers as percent of CD8(+)/IFN-γ(+) T cells after in vitro stimulation against peptide pools II and IV was notably higher than that of HLA-A2(-) recovered individuals. Based on cutoff scores calculated from the response of HLA-A2(-) recovered individuals, 31.6% and 13.3% of HLA-A2(+) recovered persons responded above cutoff in pools II and IV, respectively. ELISpot and ELISA results confirmed flow cytometry analysis. The response of HLA-A2(-) recovered individuals against peptide pools I and III was detected similar and even higher than HLA-A2(+) recovered individuals. CONCLUSION: Using in silico prediction we demonstrated specific response to LmsTI-1 (pool II) and LPG-3- (pool IV) related peptides specifically presented in HLA-A*0201 context. This is among the very few reports mapping L. major epitopes for human HLA types. Studies like this will speed up polytope vaccine idea towards leishmaniasis.


Subject(s)
Antigens, Protozoan/genetics , Antigens, Protozoan/immunology , CD8-Positive T-Lymphocytes/immunology , Epitopes, T-Lymphocyte/immunology , HLA-A2 Antigen/immunology , Leishmania major/genetics , Leishmania major/immunology , Adolescent , Adult , Aged , Cells, Cultured , Child , Computational Biology/methods , Cytokines/metabolism , Female , Humans , Leukocytes, Mononuclear/immunology , Male , Middle Aged , Software , Young Adult
8.
Mol Cancer ; 10: 3, 2011 Jan 07.
Article in English | MEDLINE | ID: mdl-21211062

ABSTRACT

Cancer vaccines are the promising tools in the hands of the clinical oncologist. Many tumor-associated antigens are excellent targets for immune therapy and vaccine design. Optimally designed cancer vaccines should combine the best tumor antigens with the most effective immunotherapy agents and/or delivery strategies to achieve positive clinical results. Various vaccine delivery systems such as different routes of immunization and physical/chemical delivery methods have been used in cancer therapy with the goal to induce immunity against tumor-associated antigens. Two basic delivery approaches including physical delivery to achieve higher levels of antigen production and formulation with microparticles to target antigen-presenting cells (APCs) have demonstrated to be effective in animal models. New developments in vaccine delivery systems will improve the efficiency of clinical trials in the near future. Among them, nanoparticles (NPs) such as dendrimers, polymeric NPs, metallic NPs, magnetic NPs and quantum dots have emerged as effective vaccine adjuvants for infectious diseases and cancer therapy. Furthermore, cell-penetrating peptides (CPP) have been known as attractive carrier having applications in drug delivery, gene transfer and DNA vaccination. This review will focus on the utilization of different vaccine delivery systems for prevention or treatment of cancer. We will discuss their clinical applications and the future prospects for cancer vaccine development.


Subject(s)
Cancer Vaccines/administration & dosage , Drug Delivery Systems , Neoplasms/prevention & control , Vaccines, DNA/administration & dosage , Cell-Penetrating Peptides , Dendritic Cells/immunology , Gene Transfer Techniques , Genetic Therapy , Genetic Vectors , Immunity, Mucosal , Liposomes , Nanoparticles , Neoplasms/therapy , Vaccines, Subunit/administration & dosage , Vaccines, Virus-Like Particle/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...